APA

Montejo A. L., Deakin J. F. W., Gaillard R., Harmer C., Meyniel F., Jabourian A., Gabriel C., Gruget C., Klinge C., MacFayden C., Milligan H., Mullings E. & Goodwin G. (20160623). Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. : Journal of psychopharmacology (Oxford, England).

Chicago

Montejo Angel L, Deakin J F W, Gaillard Raphael, Harmer Catherine, Meyniel Florent, Jabourian Artin, Gabriel Cecilia, Gruget Celine, Klinge Corinna, MacFayden Christine, Milligan Holly, Mullings Emma and Goodwin Guy. 20160623. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. : Journal of psychopharmacology (Oxford, England).

Harvard

Montejo A. L., Deakin J. F. W., Gaillard R., Harmer C., Meyniel F., Jabourian A., Gabriel C., Gruget C., Klinge C., MacFayden C., Milligan H., Mullings E. and Goodwin G. (20160623). Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. : Journal of psychopharmacology (Oxford, England).

MLA

Montejo Angel L, Deakin J F W, Gaillard Raphael, Harmer Catherine, Meyniel Florent, Jabourian Artin, Gabriel Cecilia, Gruget Celine, Klinge Corinna, MacFayden Christine, Milligan Holly, Mullings Emma and Goodwin Guy. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. : Journal of psychopharmacology (Oxford, England). 20160623.